ARTICLE | Clinical News
Vyvanse lisdexamfetamine dimesylate chewable tablets regulatory update
April 25, 2016 7:00 AM UTC
Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Product: Vyvanse lisdexamfetamine dimesylate chewable tablets Business: Neurology Shire submitted an NDA to FDA for Vyvanse lisdexamfetamine dimesylat...